Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity

Pediatrics - United States
doi 10.1542/peds.2015-3218
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Academy of Pediatrics (AAP)

Related search

Neurodevelopmental Outcomes After Extreme Prematurity Comparing Bevacizumab to Laser Surgery for Type 1 Retinopathy of Prematurity

Developmental Medicine and Child Neurology
Child HealthDevelopmental NeurosciencePediatricsPerinatologyNeurology
2018English

Comparison of Intravitreal Ranibizumab and Bevacizumab Treatment for Retinopathy of Prematurity

Arquivos Brasileiros de Oftalmologia
MedicineOphthalmology
2015English

Intravitreal Bevacizumab for Retinopathy of Prematurity in Infants Ineligible for Laser Therapy*

Turkish Journal of Medical Sciences
Medicine
2016English

Case of Endophthalmitis Following Intravitreal Injections of Bevacizumab

Clinical Ophthalmology
Ophthalmology
2010English

Intravitreal Bevacizumab as Single Drug Therapy for Retinopathy of Prematurity in 12 Patients

Archivos Argentinos de Pediatria
Child HealthPediatricsPerinatology
2014English

A Lower Dose of Intravitreal Bevacizumab Effectively Treats Retinopathy of Prematurity

Journal of AAPOS
Child HealthOphthalmologyPediatricsPerinatology
2018English

Different Refractive Errors in Triplets With Retinopathy of Prematurity Treated With Bevacizumab

Journal of Pediatric Ophthalmology and Strabismus
MedicineChild HealthOphthalmologyPediatricsPerinatology
2012English

Screening for Retinopathy of Prematurity.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1992English

Retinopathy of Prematurity

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy